Allworth Financial’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADCT
ACM
Allworth Financial's ADCT Position: Q3 2026 in Review
Allworth Financial held its ADC Therapeutics (ADCT) position steady in Q3 2026 at 104 shares worth $112. The position accounts for ﹤0.01% of the portfolio, ranked #5132.
Allworth Financial first reported a position in ADCT in Q3 2025 and has held it in 5 quarters since. The position peaked at $439 in Q1 2026. 75 funds tracked by Wall St. Rank hold ADCT as of Q3 2026.
- Allworth Financial held 104 shares of ADC Therapeutics worth $112 as of Q3 2026.
- Allworth Financial left its ADC Therapeutics share count unchanged in Q3 2026.
- ADC Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #5132 holding.
- Allworth Financial first reported a position in ADC Therapeutics in Q3 2025 and has held it in 5 quarters since.
- Allworth Financial's ADC Therapeutics position peaked at $439 in Q1 2026.
- 75 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2026.
Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.